{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:21:24Z","timestamp":1788009684435,"version":"build-2784847793"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The clinical efficacy of Xianling Gubao capsule (XLGB) and its combination therapy in the treatment of postmenopausal osteoporosis (PMOP) was systematically evaluated by frequency-based network meta-analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched the China National Knowledge Infrastructure (CNKI), Wanfang, SinoMed, PubMed, Embase and Cochrane Library databases to identify clinical trials of XLGB for the treatment of PMOP from the establishment of each database to November 22, 2021. The quality of the included studies was evaluated by using the risk of bias assessment tool version 2.0 (Rob 2.0) recommended by Cochrane. Stata 14.0 was applied for statistical analysis of the data, and the surface under the cumulative ranking curve (SUCRA) was used to rank the intervention measures of each outcome index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This study included 22 clinical trials (including 19 RCTs and 3 non-RCTs) involving 12 drug therapies. According to the results of the network meta-analysis and SUCRA, the best three interventions for improving lumbar bone mineral density (BMD) are XLGB+BP+calcium (83.7%), XLGB+BP (68.5.7%) and XLGB+VD (67.1%). XLGB+calcium was the best combination regimen for improving femoral neck BMD and increasing bone Gla protein (BGP) and alkaline phosphatase (ALP) contents in serum. The SUCRA values of XLGB+calcium for improving the three outcome indicators were 68.0%, 59.5% and 82.1%, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The results of this network meta-analysis show that combined application of XLGB can effectively improve BMD and serum BGP and ALP compared to calcium alone, VD or BP. In the future, multicenter, large-sample and double-blind clinical RCTs should be carried out to supplement and verify the results of this study.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.839885","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T13:41:57Z","timestamp":1645191717000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Comparative Efficacy of Xianling Gubao Capsules in Improving Bone Mineral Density in Postmenopausal Osteoporosis: A Network Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Ming-hui","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-long","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-xuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-feng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1717468","article-title":"Combination and Sequential Treatment in Women With Postmenopausal Osteoporosis","volume":"21","author":"Anastasilakis","year":"2020","journal-title":"Expert Opin Pharmaco"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S231759","article-title":"Diagnosis of Presarcopenia Using Body Height and Arm Span for Postmenopausal Osteoporosis","volume":"15","author":"Ono","year":"2020","journal-title":"Clin Interv Aging"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: Medical Management, Epidemiology and Economic Burden","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporosis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal Osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-017-0701-3","article-title":"Persistence With Denosumab Therapy in Women Affected by Osteoporosis With Fragility Fractures: A Multicenter Observational Real Practice Study in Italy","volume":"40","author":"Migliaccio","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-019-01436-8","article-title":"Myostatin as a Potential Biomarker to Monitor Sarcopenia in Hip Fracture Patients Undergoing a Multidisciplinary Rehabilitation and Nutritional Treatment: A Preliminary Study","volume":"32","author":"de Sire","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.695832","article-title":"The Efficacy and Safety of Chinese Herbal Medicine Xianling Gubao Capsule Combined With Alendronate in the Treatment of Primary Osteoporosis: A Systematic Review and Meta-Analysis of 20 Randomized Controlled Trials","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.lfs.2016.01.024","article-title":"Natural Products for Treatment of Osteoporosis: The Effects and Mechanisms on Promoting Osteoblast-Mediated Bone Formation","volume":"147","author":"An","year":"2016","journal-title":"Life Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical Tools for Network Meta-Analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PloS One"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctcp.2020.101260","article-title":"Comparative Effectiveness of Breathing Exercises in Patients With Chronic Obstructive Pulmonary Disease","volume":"41","author":"Marotta","year":"2020","journal-title":"Complement Ther Clin Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1577-2","article-title":"The First Multicenter and Randomized Clinical Trial of Herbal Fufang for Treatment of Postmenopausal Osteoporosis","volume":"23","author":"Zhu","year":"2012","journal-title":"Osteoporosis Int"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.2095-0616.2021.17.063","article-title":"Efficacy of Alendronate Sodium Combined With Xianling Gubao in the Treatment of Osteoporosis in Middle-Aged and Elderly Postmenopausal Patients","volume":"11","author":"Zhang","year":"2021","journal-title":"China Med Pharm"},{"key":"B15","article-title":"Clinical Study of Fushanmei Combined With Xianlinggubao in the Treatment of Osteocalcin, Calcitonin and Bone Mineral Density in Postmenopausal Osteoporosis","volume":"147","author":"Wu","year":"2008","journal-title":"Contemp Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-5018.2016.09.211","article-title":"Clinical Study on the Changes of Osteocalcin, Calcitonin and Bone Mineral Density of Fushanmei Combined With Xianlinggubao in the Treatment of Postmenopausal Osteoporosis","volume":"9","author":"Li","year":"2016","journal-title":"Oriental Diet Ther Health Care"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2014.02.032","article-title":"Clinical Observation of Calcitriol Combined With Xianlinggubao in the Treatment of Postmenopausal Osteoporosis","volume":"46","author":"Ni","year":"2014","journal-title":"J New Chin Med"},{"key":"B18","volume-title":"Clinical Study of Calcitriol Combined With Xianlinggubao in Treatment of Women With Osteoporosis","author":"Wang","year":"2014"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1672-2779.2019.15.026","article-title":"Clinical Observation on Jintiange Capsules in the Treatment of Postmenopausal Osteoporosis","volume":"17","author":"Lai","year":"2019","journal-title":"Chin Med Modern Distance Educ China"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3321\/j.issn:1003-5370.2007.08.009","article-title":"Effects of Migu Tablet on Bone Mineral Density, Serum Levels of Osteoprotegerin and Its Ligand and Bone Metabolic Markers in Patients With Postmenopausal Osteoporosis","volume":"27","author":"Dai","year":"2007","journal-title":"Chin J Integrated Tradit Western Med"},{"key":"B21","first-page":"99","article-title":"Effects of Xianling Gubao Capsule on Bone Mineral Density and Cytokines in Postmenopausal Osteaporofic Patients","volume":"10","author":"Zhang","year":"2004","journal-title":"Chin J Osteoporosis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.13359\/j.cnki.gzxbtcm.2005.03.008","article-title":"Preventive and Therapeutic Effects of Xianling Gubao Capsules for Postmenopausal Osteoporosis","volume":"22","author":"Wu","year":"2005","journal-title":"J Guangzhou Univ Tradit Chin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.13194\/j.jlunivtcm.2009.01.96.xum.106","article-title":"Clinical Observation of Xianlinggubao Plus Alendronate on Postmenopausal Osteoporosis","volume":"11","author":"Xu","year":"2009","journal-title":"J Liaoning Univ Tradit Chin Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3969\/j.issn.1008-9276.2021.01.007","article-title":"Effects of Xianling Gubao Jiaonang on Lipid Metabolism, Bone Metabolism and Bone Density in Postmenopausal Osteoporosis Patients With Obesity","volume":"33","author":"Cai","year":"2021","journal-title":"J Henan Med Coll"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.13261\/j.cnki.jfutcm.002170","article-title":"Clinical Research on Xianling Gubao Capsule and Rocalirol Tablet in Treating 35 Cases of Postmenopausal Osteoporosis Related Pain","volume":"19","author":"Nie","year":"2009","journal-title":"Rehabil Med"},{"key":"B26","article-title":"Xianling Gubao Capsule Combined With Caltech D in the Treatment of Postmenopausal Osteoporosis","volume":"22","author":"Wu","year":"2010","journal-title":"Strait Pharm J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-1245.2019.07.027","article-title":"Alfacalcidol Capsules Combined With Xianling Gubao Capsules in Treatment of Postmenopausal Osteoporosis","volume":"25","author":"Wang","year":"2019","journal-title":"Int Med Health Guidance News"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.11966\/j.issn.2095-994X.2020.06.05.61","article-title":"Effect of Xianling Gubao Capsule Combined With Calcium Acetate Capsule on Post- Menopausal Women\u2019s Osteoporosis","volume":"6","author":"Li","year":"2020","journal-title":"World J Complex Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"827","DOI":"10.13699\/j.cnki.1001-6821.2015.10.019","article-title":"Effect of Xianlinggubao Capsule in the Treatment of Postmenopausal Osteoporosis and its Effect on Osteoprotegerin, Receptor Activator of Nuclear Factor - \u03bab Ligand","volume":"31","author":"Chen","year":"2015","journal-title":"Chin J Clin Pharmacol"},{"key":"B30","article-title":"Clinical Observation of Xianling Gubao Capsule in the Treatment of Postmenopausal Osteoporosis","volume":"14","author":"Shang","year":"2007","journal-title":"Chin J Integrated Tradit Western Med Intensive Crit Care"},{"key":"B31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.16254\/j.cnki.53-1120\/r.2021.06.012","article-title":"Clinical Observation of Xianling Gubao Capsule in the Treatment of Postmenopausal Women With Osteoporosis","volume":"42","author":"Liu","year":"2021","journal-title":"Yunnan J Tradit Chin Med Materia Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.16367\/j.issn.1003-5028.2017.04.0244","article-title":"The Clinical Research Into Menopausal Osteoporosis Treated With Xianlinggubao Capsules","volume":"37","author":"Song","year":"2017","journal-title":"Henan Tradit Chin Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1005-9202.2020.03.041","article-title":"Effects of Xianling Gubao Combined With Alendronate on Bone Metabolic Indexes, Bone Mineral Density and Symptoms of Bone Pain in Postmenopausal Osteoporosis","volume":"40","author":"Zhou","year":"2020","journal-title":"Chin J Gerontol"},{"key":"B34","article-title":"Xianlinggubao Combined With Fushanmei in the Treatment of Postmenopausal Osteoporosis","volume":"23","author":"Zhuang","year":"2013","journal-title":"Zhejiang J Integrated Tradit Chin Western Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118184","article-title":"In Vivo Screening for Anti-Osteoporotic Fraction From Extract of Herbal Formula Xianlinggubao in Ovariectomized Mice","volume":"10","author":"Wang","year":"2015","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00273","article-title":"Beneficial Effects and Toxicity Studies of Xian-Ling-Gu-Bao on Bone Metabolism in Ovariectomized Rats","volume":"8","author":"Wu","year":"2017","journal-title":"Front Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11626-020-00530-w","article-title":"Xian-Ling-Gu-Bao Protects Osteoporosis Through Promoting Osteoblast Differentiation by Targeting miR-100-5p\/KDM6B\/RUNX2 Axis","volume":"57","author":"Ai","year":"2021","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"B38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1142\/S0192415X99000057","article-title":"The Association Between Postmenopausal Osteoporosis and Kidney-Vacuity Syndrome in Traditional Chinese Medicine","volume":"27","author":"Chen","year":"1999","journal-title":"Am J Chin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/5687421","article-title":"The Efficacy and Safety of Traditional Chinese Medicine Tonifying-Shen (Kidney) Principle for Primary Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"2020","author":"Liang","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF03026324","article-title":"Phytoestrogen-Rich Herb Formula \u201cXLGB\u201d Prevents OVX-Induced Deterioration of Musculoskeletal Tissues at the Hip in Old Rats","volume":"23","author":"Qin","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20170705.007","article-title":"Systemic Evaluation and Meta-Analysis of Xianling Gubao Capsule in Treatment of Primary Osteoporosis in Randomized Controlled Trials","volume":"42","author":"Wang","year":"2017","journal-title":"China J Chin Materia Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1006-7108.2020.05.017","article-title":"Analysis of Pharmacological Mechanism of XianlingGubao Capsule in Treating Osteoporosis Based on Network Pharmacology","volume":"26","author":"Qi","year":"2020","journal-title":"Chin J Osteoporosis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.19378\/j.issn.1003-9783.2018.04.004","article-title":"Effects of New Xianling Gubao Capsule on Ovariectomized Osteoporotic Rats","volume":"29","author":"Liu","year":"2018","journal-title":"Tradit Chin Drug Res Clin Pharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.839885\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T13:42:25Z","timestamp":1645191745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.839885\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.839885"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.839885","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"839885"}}